Insufficient expression of cyclooxygenase-2 protein is associated with retarded degradation of aggregated protein in diabetic glomeruli

Journal of Pharmacological Sciences

Volumn 102, Issue 2, 2006, Pages 173-181

  Hirasawa, Yasushi ^a,b   Muramatsu, Aiko ^a   Suzuki, Yoshio ^a   Nagamatsu, Tadashi ^a  

^a MEIJO UNIVERSITY   (Japan)

^b Nihon Bioresearch Inc   (Japan)

Author keywords

Aggregated bovine serum albumin; Cyclooxygenase 2; Diabetic; Glomeruli; Streptozotocin

Indexed keywords

5 (4 CHLOROPHENYL) 1 (4 METHOXYPHENYL) 3 TRIFLUOROMETHYL 1H PYRAZOLE; BOVINE SERUM ALBUMIN; CYCLOOXYGENASE 2; MESSENGER RNA; NIFLUMIC ACID; PROSTAGLANDIN E2;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DIABETIC NEPHROPATHY; DRUG MECHANISM; ENZYME METABOLISM; HORMONE SYNTHESIS; MOUSE; NONHUMAN; PROTEIN AGGREGATION; PROTEIN ANALYSIS; PROTEIN DEGRADATION; PROTEIN EXPRESSION; WESTERN BLOTTING;

EID: 33750606087     PISSN: 13478613     EISSN: 13478648     Source Type: Journal    
DOI: 10.1254/jphs.FPJ06010X     Document Type: Article

References (33)

1. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993;329:977-986.
2. Schleicher E, Wieland OH. Changes of human glomerular basement membrane in diabetes mellitus. J Clin Chem Clin Biochem. 1984;22:223-227.
3. Suzuki D. Measurement of the extracellular matrix in glomeruli from patients with diabetic nephropathy using an automatic image analyzer. Jpn J Nephrol. 1994;36:1209-1215.
4. Mancilla JR. Phagocytosis of heat-aggregated immunoglobulin by mesangial cells. An immunoperoxidase and acid phosphatase study. Lab Invest. 1982;46:243-253.
5. Stricker GE, Mannik M, Tung MY. Role of marrow-derived monocytes and mesangial cells in removal of immune complex from renal glomeruli. J Exp Med. 1979;149:127-136.
6. Komers R, Lindsley JN, Oyama TT, Schutzer WE, Reed JF, Mader SL, et al. Immunohistochemical and functional correlations of renal cyclooxygenase-2 in experimental diabetes. J Clin Invest. 2001;107:889-898.
7. Schambelan M, Blake S, Sraer J, Bens M, Nivez MP, Wahbe F. Increased prostaglandin production by glomeruli isolated from rats with streptozotocin-induced diabetes mellitus. J Clin Invest. 1985;75:404-412.
8. Nagamatsu T, Ishikami H, Nishiyama T, Suzuki Y. Induction of cyclooxygenase-2 expression in glomeruli by aggregated protein. Jpn J Pharmacol. 2002;89:373-379.
9. 2 in clearance of aggregated protein via protein kinase A in glomeruli. Jpn J Pharmacol. 2001;85:139-145.
10. DeWitt DL. Prostaglandin endoperoxide syntheses: regulation of enzyme expression. Biochim Biophys Acta. 1991;1083:121-134.
11. Smith WL, Marnett LJ, DeWitt DL. Prostaglandin and thromboxane biosynthesis. Pharmacol Ther. 1991;9:153-179.
12. Kujubu DA, Fletcher BS, Varnum BC, Lim RW, Herschman HR. TIS10 a phorbol ester tumor promoter-inducible mRNA from Swiss 3T3 cells, encodes a novel prostaglandin synthase/cyclooxygenase homologue. J Biol Chem. 1991;266:12866-12872.
13. Funk CD, Funk LB, Kennedy ME, Pong AS, Fitzgerald GA. Human platelet/erythroleukemia cell prostaglandin G/H synthase: cDNA cloning, expression, and gene chromosomal assignment. FASEB J. 1991;5:2304-2312.
14. Herschman HR. Prostaglandin synthase 2. Biochim Biophys Acta. 1996;1299:125-140.
15. Smith WL, DeWitt DL, Garavito RM. Cyclooxygenases, structural, cellular and molecular biology. Annu Rev Biochem. 2000;69:145-182.
16. Nagamatsu T, Hirasawa Y, Matsui Y, Ohtsu S, Yamane K, Toyoshi T, et al. Increase in the deposition of aggregated protein in the glomeruli of spontaneously diabetic mice. J Pharmacol Sci. 2005;99:287-293.
17. 1 on disposal of heat-aggregated bovine serum albumin in the glomerulus. Jpn J Pharmacol. 1988;46:397-402.
18. Ford PM. Glomerular localization of aggregated protein in mice; effect of strain difference and relationship to systemic macrophage function. Br J Exp Pathol. 1975;56:307-313.
19. 2 interferes with a disposal process of aggregated protein in glomeruli. Jpn J Pharmacol. 1997;75:381-390.
20. Gabra BH, Sirois P. Beneficial effect of chronic treatment with the selective bradykinin B1 receptor antagonists, R-715 and R-954, in attenuating streptozotocin-diabetic thermal hyperalgesia in mice. Peptides. 2003;24:1131-1139.
21. Shitashige M, Morita I, Murota S. Different substrate utilization between prostaglandin endoperoxide H synthase-1 and -2 in NIH3T3 fibroblasts. Biochim Biophys Acta. 1998;1389:57-66.
22. Craven PA, Patterson MC, DeRubertis FR. Role of enhanced arachidonate availability through phospholipase A2 pathway in mediation of increased prostaglandin synthesis by glomeruli from diabetic rats. Diabetes. 1988;37:429-435.
23. Craven PA, DeRubertis FR. Role for local prostaglandin and thromboxane production in the regulation of glomerular filtration rate in the rat with streptococci-induced diabetes. J Lab Clin Med. 1989;113:674-681.
24. Kreisberg JI, Patel PY. The effects of insulin, glucose and diabetes on prostaglandin production by rat kidney glomeruli and cultured glomerular mesangial cells. Prostaglandins Leukot Med. 1983;11:431-442.
25. Barnett R, Scharschmidt L, Ko YH, Schlondorff D. Comparison of glomerular and mesangial prostaglandin synthesis and glomerular contraction in two rat models of diabetes mellitus. Diabetes. 1987;36:1468-1475.
26. Williams B, Schrier RW. Glucose-induced protein kinase C activity regulates arachidonic acid release and eicosanoid production by cultured glomerular mesangial cells. J Clin Invest. 1993;92:2889-2896.
27. Lee TS, Saltsman KA, Ohashi H, King GL. Activation of protein kinase C by elevation of glucose concentration: proposal for a mechanism in the development of diabetic vascular complication. Proc Natl Acad Sci U S A. 1989;86:5141-5145.
28. Nemenoff RA, Winitz S, Qian NX, Van Putten V, Johnson GL, Heasley LE. Phosphorylation and activation of a high molecular weight form of phospholipase A2 by p45 microtubule-associated protein 2 kinase and protein kinase C. J Biol Chem. 1993;268:1960-1964.
29. Dixon DA, Kaplan CD, McIntyre TM, Zimmerman GA, Prescott SM. Post-transcriptional control of cyclooxygenase-2 gene expression. The role of the 3′-untranslated region. J Biol Chem. 2000;275:11750-11757.
30. Pages G, Berra E, Milanini J, Levy AP, Pouyssegur J. Stress-activated protein kinases (JNK and p38/HOG) are essential for vascular endothelial growth factor mRNA stability. J Biol Chem. 2000;275:26484-26491.
31. Weigert C, Sauer U, Brodbeck K, Pfeiffer A, Haring HU, Schleicher ED. AP-1 protein mediate hyperglycemia-induced activation of the human TGFβ-1 promoter in mesangial cells. J Am Soc Nephol. 2000;11:2007-2016.
32. Haneda M, Araki S, Togawa M, Sugimoto T, Isono M, Kikkawa R. Mitogen-activated protein kinase cascade4 is activated in glomeruli of diabetic rats and glomerular mesangial cells cultured under high glucose conditions. Diabetes. 1999;46:847-853.
33. Igarashi M, Wakasaki H, Takahara N, Hoshiya M. Mechanisms of mitogen-activated protein kinase via different pathways. J Clin Invest. 1999;103:185-195.